Emerging market equities have outperformed their developed-market peers so far this year. But these stocks still trade at attractive valuations for opportunistic investors who are late to the rally. Read More
The following search results are from Investing Daily's public research only. Please Log In to search your premium services.
Results
At this early stage in the security registration process, SandRidge Mississippian Trust II’s (NYSE: SDR) tax advantages, exposure to oil prices and potential for distribution growth make the stock worthy of consideration. However, much of this depends on the price at which the trust debuts; no stock is a buy at any price. Read More
When attempting to value banks, different rules apply. Why debt and cash are trickier concepts in the bank context. Read More
How will Research in Motion fare after RIM's decision to replace co-CEOs, Mike Lazaridis and Jim Balsillie? Analysts weigh in. Read More
Australia's Big Four banks are under scrutiny for their exposure to Europe and wholesale funding markets. These concerns are legitimate and overblown. Read More
Last Thursday, I hosted one of my regular Live Chat sessions with readers of The Energy Strategist. Here are my responses to a handful of common questions from subscribers. Read More
Master limited partnerships (MLP) are one of the surest groups for solid growth and sustainable distributions. Read More
Keystone XL--formally the Keystone Gulf Coast Expansion Project--was rejected this week. But it’s on track to come on line in late 2014. Read More
The boom in onshore oil and gas drilling continues to redound throughout the US economy. Read More
2012 is shaping up to be an "annus horribilis" for the drug industry thanks to a large number of patent expirations. Some drug stocks will thrive regardless and Jim names a few. Read More
Stock Talk Results
No Comments Found